Alpha Omega Wealth Management’s Pfizer PFE Stock Holding History

Alpha Omega Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.26M	Buy	218,573 +5,935	+3%	+$155K	0.8%	39
2026 Q1	$5.97M	Buy	212,638 +8,529	+4%	+$227K	0.97%	29
2025 Q4	$5.08M	Sell	204,109 -2,155	-1%	-$54.3K	0.84%	31
2025 Q3	$5.26M	Buy	206,264 +16,527	+9%	+$408K	0.87%	34
2025 Q2	$4.6M	Buy	189,737 +10,167	+6%	+$237K	0.82%	37
2025 Q1	$4.55M	Buy	179,570 +42,083	+31%	+$1.1M	0.87%	32
2024 Q4	$3.65M	Sell	137,487 -38,797	-22%	-$1.05M	0.69%	49
2024 Q3	$5.1M	Buy	176,284 +1,150	+0.7%	+$33.5K	0.94%	28
2024 Q2	$4.9M	Buy	175,134 +11,010	+7%	+$303K	0.94%	28
2024 Q1	$4.55M	Buy	164,124 +14,736	+10%	+$409K	0.85%	36
2023 Q4	$4.3M	Buy	149,388 +16,875	+13%	+$510K	0.71%	35
2023 Q3	$4.4M	Buy	132,513 +19,458	+17%	+$688K	0.76%	31
2023 Q2	$4.15M	Sell	113,055 -852	-0.7%	-$33.2K	0.7%	37
2023 Q1	$4.65M	Buy	113,907 +1,915	+2%	+$82.7K	0.8%	30
2022 Q4	$5.74M	Sell	111,992 -1,411	-1%	-$67.6K	1.02%	23
2022 Q3	$4.96M	Sell	113,403 -3,421	-3%	-$166K	0.95%	22
2022 Q2	$6.13M	Sell	116,824 -1,031	-0.9%	-$52.5K	1.09%	20
2022 Q1	$6.1M	Sell	117,855 -1,760	-1%	-$91.3K	0.96%	24
2021 Q4	$6.64M	Sell	119,615 -17,241	-13%	-$854K	1.02%	18
2021 Q3	$5.89M	Sell	136,856 -4,513	-3%	-$200K	0.96%	20
2021 Q2	$5.54M	Buy	141,369 +1,918	+1%	+$74.6K	0.91%	26
2021 Q1	$5.05M	Buy	139,451 +8,330	+6%	+$296K	0.88%	28
2020 Q4	$4.83M	Sell	131,121 -6,033	-4%	-$221K	0.82%	21
2020 Q3	$4.78M	Sell	137,154 -1,173	-0.8%	-$41.1K	0.67%	18
2020 Q2	$4.29M	Sell	138,327 -6,719	-5%	-$228K	0.65%	19
2020 Q1	$4.49M	Buy	145,046 +3,551	+3%	+$121K	0.83%	14
2019 Q4	$5.26M	Buy	141,495 +2,397	+2%	+$85.4K	0.84%	17
2019 Q3	$4.89M	Buy	139,098 +27,929	+25%	+$1.02M	0.79%	19
2019 Q2	$4.57M	Buy	111,169 +3,732	+3%	+$148K	1.94%	8
2019 Q1	$4.33M	Sell	107,437 -1,665	-2%	-$66.7K	1.94%	6
2018 Q4	$4.52M	Sell	109,102 -12,590	-10%	-$523K	2.27%	6
2018 Q3	$5.09M	Sell	121,692 -948	-0.8%	-$36.5K	2.28%	4
2018 Q2	$4.22M	Buy	122,640 +3,263	+3%	+$112K	2.07%	6
2018 Q1	$4.02M	Buy	119,377 +2,285	+2%	+$78.6K	2.02%	8
2017 Q4	$4.02M	Buy	117,092 +1,276	+1%	+$43.5K	1.97%	10
2017 Q3	$3.92M	Buy	115,816 +1,125	+1%	+$36.2K	1.96%	10
2017 Q2	$3.65M	Buy	114,691 +3,725	+3%	+$117K	1.88%	9
2017 Q1	$3.6M	Buy	110,966 +3,358	+3%	+$106K	1.92%	9
2016 Q4	$3.32M	Buy	107,608 +18,554	+21%	+$566K	1.75%	12
2016 Q3	$2.86M	Sell	89,054 -684	-0.8%	-$22.9K	2.28%	15
2016 Q2	$3M	Buy	89,738 +217	+0.2%	+$6.93K	2.53%	10
2016 Q1	$2.52M	Buy	89,521 +1,718	+2%	+$49.1K	2.1%	21
2015 Q4	$2.69M	Buy	+87,803	New	+$2.76M	2.35%	12

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Alpha Omega Wealth Management's PFE Position: Q2 2026 in Review

Alpha Omega Wealth Management increased its Pfizer (PFE) stake by 2.8% in Q2 2026, buying an estimated $155K and bringing the position to 218,573 shares worth $5.26M. The position accounts for 0.8% of the portfolio, ranked #39.

Alpha Omega Wealth Management first reported a position in PFE in Q4 2015 and has held it in 43 quarters since. The position peaked at $6.64M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Alpha Omega Wealth Management held 218,573 shares of Pfizer worth $5.26M as of Q2 2026.
Alpha Omega Wealth Management bought 5,935 Pfizer shares in Q2 2026, an estimated $155K.
Pfizer made up 0.8% of Alpha Omega Wealth Management's portfolio in Q2 2026, its #39 holding.
Alpha Omega Wealth Management first reported a position in Pfizer in Q4 2015 and has held it in 43 quarters since.
Alpha Omega Wealth Management's Pfizer position peaked at $6.64M in Q4 2021.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Alpha Omega Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.